RSV costs Türkiye’s healthcare system over 24 bln liras: Study
Respiratory Syncytial Virus (RSV), a common cause of serious respiratory illnesses in infants, is placing a significant financial burden on Türkiye’s healthcare system, with a total cost exceeding 24.2 billion Turkish Liras ($624.7 million) per year, according to a new study.